The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPEU.L Regulatory News (DPEU)

  • There is currently no data for DPEU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

28 Jun 2017 07:30

RNS Number : 3569J
Morgan Stanley & Co. Int'l plc
28 June 2017
 

Pre-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any jurisdiction in which such distribution would be unlawful.

 

 

DP Eurasia N.V.

Stabilisation Notice

 

Morgan Stanley & Co. International Plc (contact: James Manson-Bahr; telephone: 020 7425 3672) hereby gives notice that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014).

 

The Securities:

Issuer:

DP Eurasia N.V.

Offering securities:

Ordinary Shares of €0.12 each

ISIN: NL0012328801

Offering description:

Initial Public Offering of Ordinary Shares

Offering size:

74,130,435 Ordinary Shares (excluding Over-allotment Option)

Offer price:

200 pence per Ordinary Share

Stabilisation:

Stabilisation Manager:

Morgan Stanley & Co. International Plc of 25 Cabot Square, Canary Wharf, London E14 4QA, United Kingdom

Stabilisation period expected to start on:

Approximately 8.00 a.m. (London time) on 28 June 2017

Stabilisation period expected to end no later than:

Close of business on 27 July 2017

Maximum size of over-allotment facility:

11,119,565 Ordinary Shares

Conditions of use of over-allotment facility:

 

May be exercised in whole or in part by the Stabilisation Manager, to the extent permitted by applicable law, at any time during the period commencing with conditional dealings and ending 30 days thereafter

Over-allotment Option:

Terms:

The Stabilisation Manager may over-allot the securities to the extent permitted in accordance with applicable law

Exercise period:

30 days from the start of conditional dealings (ending close of business 27 July 2017)

 

 

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEFRMTTMBBTTPR
Date   Source Headline
19th Sep 20231:41 pmRNSPDMR and PCA Notification
19th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSNotification of Interim Results
21st Aug 20237:00 amRNSUpdate on Russian Business
27th Jul 20237:00 amRNSTrading Update
25th Jul 20237:00 amRNSNotice of Trading Update
13th Jun 20232:00 pmRNSResults of 2022 Annual General Meeting
8th Jun 20237:00 amRNSIssue of Equity under the LTIP
31st May 20237:00 amRNSTrading Update
24th May 20237:00 amRNSNotice of Trading Update
9th May 20237:00 amRNSPDMR and PCA Notification
2nd May 202312:57 pmRNSIntended Appointment of INED
2nd May 202312:54 pmRNSNotice of 2023 Annual General Meeting
20th Apr 20237:00 amRNS2022 Annual Report and Accounts
12th Apr 20237:00 amRNSPreliminary Results
6th Apr 20232:07 pmRNSDirectorate Change
5th Apr 20237:00 amRNSNotification of Preliminary Results
9th Feb 20234:40 pmRNSSecond Price Monitoring Extn
9th Feb 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSFY22 Trading Update
28th Dec 20227:00 amRNSStatement in response to market speculation
23rd Nov 20227:00 amRNSTrading Update
15th Nov 20227:00 amRNSNotice of Trading Update
4th Oct 20221:55 pmRNSPDMR and PCA Notification
30th Sep 20227:00 amRNSInterim Results
20th Sep 20221:30 pmRNSResults of 2022 Extraordinary General Meeting
7th Sep 20227:00 amRNSIssue of Equity under the LTIP
30th Aug 202212:01 pmRNSPDMR and PCA Notification
23rd Aug 20229:58 amRNSPDMR and PCA Notification
22nd Aug 20227:00 amRNSNotification of Interim Results
8th Aug 20227:00 amRNSNotice of Extraordinary General Meeting
2nd Aug 20222:47 pmRNSPDMR and PCA Notification
21st Jul 20227:00 amRNSTrading Update
20th Jul 20225:07 pmRNSRecommended Appointment of INED
19th Jul 20228:53 amRNSPDMR and PCA Notification
15th Jul 20227:00 amRNSNotice of Trading Update
4th Jul 20222:45 pmRNSPDMR and PCA Notification
27th Jun 20222:48 pmRNSPDMR and PCA Notification
24th Jun 20223:36 pmRNSPDMR and PCA Notification
8th Jun 20222:00 pmRNSResults of 2022 Annual General Meeting
6th Jun 20227:00 amRNSPDMR and PCA Notification
30th May 20222:32 pmRNSPDMR and PCA Notification
26th May 20227:00 amRNSTrading Update
24th May 202210:22 amRNSPDMR and PCA Notification
23rd May 20227:00 amRNSNotice of Trading Update
17th May 202211:39 amRNSPDMR and PCA Notification
10th May 202212:44 pmRNSPDMR and PCA Notification
3rd May 20227:00 amRNSPDMR and PCA Notification
26th Apr 202212:00 pmRNSNotice of 2022 AGM and 2021 Annual Report
25th Apr 202211:00 amRNSPDMR and PCA Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.